EMA Withdrawn: Bextra (valdecoxib) — Pharmacia - Pfizer EEIG

View source ↗

Summary

The EMA indicates Bextra (valdecoxib) has been withdrawn from the market by Pharmacia - Pfizer EEIG.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Dysmenorrhea
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Bextra (valdecoxib)

Snippet

Status: Withdrawn. Therapeutic area: Arthritis, Rheumatoid;Osteoarthritis;Dysmenorrhea. MAH: Pharmacia - Pfizer EEIG. Decision date: 03/02/2010